This feature requires access to the TospinoMall APP

Kidney cancer/liver cancer/thyroid cancer, word-of-mouth quality, authoritative certification, Laos Second Pharmaceutical Factory Cabozantinib 20mg 90 tablets/box

Indications:
20mg*90 tablets/box
1) Suitable for the treatment of patients with advanced renal cell carcinoma (RCC) can be used in combination with nivolumab as first-line treatment. 2) Suitable for patients who have previously used sorafenib to treat hepatocellular carcinoma (HCC) 3) Suitable for children and adult patients aged 12 years and above with differentiated thyroid cancer (DTC) who have received targeted therapy
Recommended dose: {For reference only, follow the doctor's advice} 1) Differentiated thyroid cancer: 60 mg each time, once a day; pediatric patients over 12 years old, 40 mg each time, once a day 2 Kidney cancer: 60 mg each time, once a day 3) Liver cancer: 60 mg each time, once a day 4) Do not eat at least 2 hours before and at least 1 hour after taking cabozantinib